China Biopharma, Inc. (OTC: CBPC)’s Chinese subsidiary - Hainan CITIC Biopharmaceutical Development Co., Ltd. - has entered into a distribution agreement with Takeda Pharmaceutical Company, Ltd. (TYO: 4502).
As part of Takeda's goal to expand sales channels in Asia, China Biopharma has begun distributing Serrapeptase tablets, and the agreement with Takeda calls for China Biopharma to distribute additional drugs as they become available.
Based in Osaka, Japan, Takeda is the largest pharmaceutical company in Japan which discovers, develops, manufactures and markets a broad range of superior pharmaceutical products.
Find more details from the full report.
Comment Preview